For many patients newly diagnosed with cancer, financial toxicity should be on top of the list of their doctors concerns: according to a US survey described on the peer-reviewed journal Cancer, published by the American Cancer [more]
A growing body of literature has described the so called “financial toxicity” of cancer, a common consequence of treatments, that sometimes leads patients to bankruptcy, and affects quality of life and clinical outcomes. “We don’t [more]
An observational cohort study just published on the peer-reviewed journal Cancer concluded that the costs of breast cancer chemotherapy vary widely in the United States, even among treatment regimens with similar efficacy, and that patients [more]